Carrick Therapeutics Limited
Privately held: no public share price
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 2 | CDK7Small molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
10 December 2025Topline resultSamuraciclibRandomised Phase 2 SUMIT-BC results presented at SABCS 2025
Carrick Therapeutics Limited · Source ↗
Financial reports
No financial reports recorded.